Mortality in patients with behavioural and psychological symptoms of dementia: a registry-based study

被引:31
|
作者
Bransvik, Vanja [1 ]
Granvik, Eva [2 ]
Minthon, Lennart [1 ,2 ]
Nordstrom, Peter [3 ]
Nagga, Katarina [1 ,4 ,5 ]
机构
[1] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden
[2] Skane Univ Hosp, Memory Clin, Malmo, Sweden
[3] Umea Univ, Dept Community Med & Rehabil, Geriatr, Umea, Sweden
[4] Linkoping Univ, Dept Acute Internal Med & Geriatr, Linkoping, Sweden
[5] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
关键词
Behavioural and psychological symptoms of dementia; mortality; BPSD; Neuropsychiatric Inventory; nursing homes; registry-based study; NURSING-HOME RESIDENTS; NEUROPSYCHIATRIC SYMPTOMS; PSYCHIATRIC-SYMPTOMS; ALZHEIMERS-DISEASE; HIP-FRACTURES; RISK; PREVALENCE; COHORT; ANTIPSYCHOTICS; PREDICTORS;
D O I
10.1080/13607863.2020.1727848
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Behavioural and psychological symptoms of dementia (BPSD) are common in patients with dementia. In the elderly population, comorbidities frequently coexist with dementia and mortality in dementia is high. The aim of this study was to investigate the impact of BPSD on mortality in severe dementia. Methods: This study of 11,448 individuals was based on linked information from the Swedish BPSD registry, the National Patient Register and the Cause of Death register. BPSD was assessed with the Neuropsychiatric Inventory (NPI). Cox proportional hazards regressions were performed for survival analysis. To study different degrees of BPSD, data was categorized into groups: no (NPI, 0 points), mild (NPI, 1-3 points on >= 1 item), moderate (NPI, 4-8 points on >= 1 item) and severe (NPI, 9-12 points on >= 1 item) BPSD based on the highest score on any of the BPSD assessed (NPI items). Results: The presence of moderate or severe BPSD was associated with a stepwise increased risk of mortality (hazard ratio (HR), 1.31; 95% confidence interval (CI), 1.08-1.60 and HR 1.74; 95% CI 1.44-2.12, respectively) compared with individuals with no BPSD. In addition, there was an association between total NPI score and mortality (HR 1.01; 95% CI 1.007-1.010). The results remained significant after multivariable adjustment for age, sex, dementia diagnosis, medication, previous myocardial infarction, hip fracture and stroke. Conclusions: The results show a stepwise increase in mortality risk with increased BPSD, highlighting the importance of adequate management of BPSD to reduce mortality in dementia.
引用
下载
收藏
页码:1101 / 1109
页数:9
相关论文
共 50 条
  • [41] Introduction to Behavioural and Psychological Symptoms of Dementia (BPSD)
    Finkel, S
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 : S2 - S4
  • [42] Instruments to measure behavioural and psychological symptoms of dementia
    van der Linde, Rianne M.
    Stephan, Blossom C. M.
    Dening, Tom
    Brayne, Carol
    INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2014, 23 (01) : 69 - 98
  • [43] Behavioural and psychological symptoms in patients with psychosis of dementia as target for pharmacotherapy with risperidone
    De Deyn, PP
    Katz, I
    Brodaty, H
    Greenspan, A
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 326 - 327
  • [44] Assessment of behavioural and psychological symptoms of dementia in veterans with a diagnosis of dementia
    Hutchinson, Deborah
    Chamberlain, Lucy
    Harrison-Dening, Karen
    INTERNATIONAL JOURNAL OF CARE AND CARING, 2021, 5 (02) : 371 - 377
  • [45] Treatment of Behavioural and Psychological Symptoms of Dementia in Frontotemporal Dementia with Citalopram
    Herrmann, Nathan
    Chow, Tiffany W.
    Black, Sandra E.
    Freedman, Morris
    Lanctot, Krista L.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A68 - A68
  • [46] Zotepine for behavioural and psychological symptoms in dementia:: An open-label study
    Rainer, MK
    Krüger-Rainer, C
    Haushofer, M
    Mucke, HAM
    CNS DRUGS, 2004, 18 (15) : 1165 - 1165
  • [47] Zotepine for behavioural and psychological symptoms in dementia -: An open-label study
    Rainer, MK
    Mucke, HAM
    Krüger-Rainer, C
    Haushofer, M
    Kasper, S
    CNS DRUGS, 2004, 18 (01) : 49 - 55
  • [48] Zotepine for Behavioural and Psychological Symptoms in Dementia: An Open-Label Study
    Michael K. Rainer
    Christine Krüger-Rainer
    Manfred Haushofer
    Hermann AM Mucke
    CNS Drugs, 2004, 18 : 1165 - 1165
  • [49] Mortality following Campylobacter infection: a registry-based linkage study
    Anders Ternhag
    Anna Törner
    Åke Svensson
    Johan Giesecke
    Karl Ekdahl
    BMC Infectious Diseases, 5
  • [50] Statins, Risk of Death and Ischemic Stroke in Patients with Dementia: A Registry-Based Observational Cohort Study
    Petek, Bojana
    Xu, Hong
    Villa-Lopez, Marta
    Winblad, Bengt
    Kramberger, Milica G.
    Eriksdotter, Maria
    Garcia-Ptacek, Sara
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (10) : 881 - 892